Blood tests may predict flap complications in breast reconstruction

NCT ID NCT07263347

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study follows 30 women undergoing DIEP flap breast reconstruction after mastectomy. Researchers will measure inflammation and oxidative stress markers in blood samples taken before and after surgery. The goal is to understand how the body responds to the temporary loss of blood flow during the procedure, which can lead to complications. No experimental treatments are given, and participation does not change standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better predict and prevent complications like fat necrosis after DIEP flap breast reconstruction.
What could go wrong
This is a small, early observational study with only 30 participants. It does not test any treatment, so direct benefits are unlikely, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, 430079, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.